|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 06, 2018 ) The report "Pyrogen Testing Market by Product (Instruments, Services, Kits and Reagents), Application (Pharmaceutical & Biotechnology, Medical Devices, Other), & by Test (In Vitro, LAL, Gel Clot, Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021", report provides a detailed overview of the major drivers, restraints, opportunities, current market trends, and strategies impacting the global pyrogen testing market along with the estimates and forecasts of the revenue and market share analysis.
The global Pyrogen Testing market was valued at USD 610.2 Million in 2016. This market is expected to grow at a CAGR of 12.2% to reach USD 1086.3 Million in 2021.
The product segments included in the report are kits and reagents, services, and instruments.
The test segments included in the report are in vitro pyrogen test, LAL (Limulus amebocyte lysate) test, and rabbit test. The LAL test is further subsegmented in to chromogenic tests, turbidimetric tests, and gel clot tests.
Browse and in-depth TOC on “Bioinformatics Market”
74 - Tables
95 - Figures
173 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/pyrogen-testing-market-255266155.html
A combination of bottom-up and top-down approaches were used to calculate market sizes and growth rates of the global pyrogen testing market and its sub-segments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of their market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub-segment and the relative differences in growth rates
Major players in the pyrogen testing market include Associates of Cape Cod, Inc. (U.S.) Charles River Laboratories International, Inc. (U.S.), Ellab A/S (Denmark), GenScript (U.S.), Hyglos GmbH (Germany), Lonza Group (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (U.S.), Wako Chemicals USA Inc. (U.S.), and Wuxi PharmaTech (CAYMAN) Inc. (China).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com
MarketsandMarkets
Mr. Shelly Singh
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
